Breaking News Instant updates and real-time market news.

BABY

Natus Medical

$39.70

-0.45 (-1.12%)

06:04
10/19/16
10/19
06:04
10/19/16
06:04

Natus Medical sees Otometrics acquisition accretive to 2017 earnings

"We now expect our recently announced acquisition of Otometrics to close on January 1, 2017. With Otometrics next year, we look forward to achieving $500 million in revenue, an important milestone for Natus. We expect Otometrics to be accretive to our 2017 earnings with a non-GAAP contribution operating margin goal for the year of 10% and a 2018 goal of 20%," said CEO Hawkins.

  • 19

    Oct

  • 29

    Nov

BABY Natus Medical
$39.70

-0.45 (-1.12%)

09/13/16
RAJA
09/13/16
UPGRADE
Target $46
RAJA
Outperform
Natus Medical upgraded to Outperform on earnings power at Raymond James
As previously reported, Raymond James analyst Jayson Bedford upgraded Natus Medical to Outperform from Market Perform with a $46 price target. Bedford recently met with management and came away more confident that capital deployment will be larger than expected, potentially increasing earnings meaningfully and acting as a catalyst for shares. He believes Natus will likely add businesses that are adjacent to their core Neurology and Newborn businesses, and would not be surprised to see it carve out a non-core business from a larger entity.
09/26/16
ROTH
09/26/16
NO CHANGE
Target $47
ROTH
Buy
Otometrics acquisition positive for Natus Medical, says Roth Capital
Roth Capital analyst Chris Lewis notes that Natus Medical announced the acquisition of Otometrics for $145M and an expected Q3 revenue shortfall. While the analyst is disappointed with the shortfall, he believes the main driver is transient in nature and should pass by the beginning of 2017. Further, Lewis sees the Otometrics acquisition as a "meaningful positive" for Natus Medical as it significantly expands the company and should allow it to reach $500M in annual revenues in 2017. He reiterates a Buy rating and $47 price target on the shares.
10/04/16
BNCH
10/04/16
INITIATION
Target $55
BNCH
Buy
Natus Medical initiated with a Buy at Benchmark
Benchmark analyst Raymond Myers started Natus Medical with a Buy rating and $55 price target.
10/18/16
ROTH
10/18/16
NO CHANGE
Target $47
ROTH
Buy
Roth Capital remains a buyer of Natus Medical ahead of results
Roth Capital analyst Chris Lewis notes that Natus Medical is expected to release full quarterly earnings on Wednesday, but has already announced a Q3 revenue shortfall. While the analyst is disappointed with the miss, he believes the likely earning accretion from Otometrics acquisition should drive stock upside over the medium to long term. He reiterates a Buy rating and $47 price target on the shares.

TODAY'S FREE FLY STORIES

AAN

Aaron's

$39.35

0.94 (2.45%)

08:49
09/20/17
09/20
08:49
09/20/17
08:49
Recommendations
Aaron's analyst commentary  »

Aaron's weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

08:49
09/20/17
09/20
08:49
09/20/17
08:49
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$55.38

-1.05 (-1.86%)

08:45
09/20/17
09/20
08:45
09/20/17
08:45
Earnings
General Mills says sees FX having 1c favorable impact to FY18 EPS 

FY18 EPS consensus $3.10.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

RSX

Market Vectors Russia ETF

$21.74

0.08 (0.37%)

, TQQQ

ProShares UltraPro QQQ

$115.32

0.49 (0.43%)

08:45
09/20/17
09/20
08:45
09/20/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

RSX

Market Vectors Russia ETF

$21.74

0.08 (0.37%)

TQQQ

ProShares UltraPro QQQ

$115.32

0.49 (0.43%)

FSLR

First Solar

$48.86

0.32 (0.66%)

IMMU

Immunomedics

$11.64

0.38 (3.37%)

JCP

J.C. Penney

$3.97

-0.18 (-4.34%)

IYR

DJ US Real Estate Index Fund

$81.01

-0.63 (-0.77%)

CHK

Chesapeake

$4.04

-0.01 (-0.25%)

SMH

Market Vectors Semiconductor

$92.60

0.24 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

08:43
09/20/17
09/20
08:43
09/20/17
08:43
Technical Analysis
Technical View: FedEx trades lower after results and outlook »

Shares were last at $213…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

08:43
09/20/17
09/20
08:43
09/20/17
08:43
Recommendations
Gemphire Therapeutics analyst commentary  »

Gemphire data support…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FDX

FedEx

$216.00

0.92 (0.43%)

08:42
09/20/17
09/20
08:42
09/20/17
08:42
Recommendations
FedEx analyst commentary  »

FedEx price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

08:42
09/20/17
09/20
08:42
09/20/17
08:42
Hot Stocks
General Mills says expects FY18 tax rate 'in-line' with FY17 »

Sees FY18 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

NVS

Novartis

$85.85

0.74 (0.87%)

08:42
09/20/17
09/20
08:42
09/20/17
08:42
Conference/Events
Novartis has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 17

    May

BABA

Alibaba

$180.07

0.09 (0.05%)

, AAPL

Apple

$158.73

0.06 (0.04%)

08:40
09/20/17
09/20
08:40
09/20/17
08:40
Conference/Events
Bloomberg to hold a forum »

Global Business Forum is…

BABA

Alibaba

$180.07

0.09 (0.05%)

AAPL

Apple

$158.73

0.06 (0.04%)

MA

MasterCard

$142.49

1.09 (0.77%)

UL

Unilever; also tag UN

$59.14

-0.09 (-0.15%)

PEP

PepsiCo

$114.49

-0.5 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 04

    Oct

  • 22

    Oct

CSOD

Cornerstone OnDemand

$39.71

-0.61 (-1.51%)

08:40
09/20/17
09/20
08:40
09/20/17
08:40
Recommendations
Cornerstone OnDemand analyst commentary  »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GIS

General Mills

08:39
09/20/17
09/20
08:39
09/20/17
08:39
Hot Stocks
General Mills says expects margin headwinds to lessen during remainder of FY18 »

Says remains on track for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GM

General Motors

$38.70

0.11 (0.29%)

08:39
09/20/17
09/20
08:39
09/20/17
08:39
Recommendations
General Motors analyst commentary  »

Citi makes case for GM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGI

Celadon Group

$6.50

-0.05 (-0.76%)

08:38
09/20/17
09/20
08:38
09/20/17
08:38
Hot Stocks
Celadon Group closing its truck driving academy »

Celadon Trucking will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

08:35
09/20/17
09/20
08:35
09/20/17
08:35
Conference/Events
Actelion has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath trends getting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMP

Ameriprise

$141.23

0.37 (0.26%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Hot Stocks
Columbia Threadneedle Investments to acquire Lionstone Investments »

Columbia Threadneedle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$3.84

-0.09 (-2.29%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Hot Stocks
Meet Group to acquire social dating app LOVOO for $70M in cash »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$130.74

0.21 (0.16%)

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Hot Stocks
Nalco Champion announces price increase for customers in all segments »

Nalco Champion, an Ecolab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SR

Spire

$75.35

-0.05 (-0.07%)

, MC

Moelis

$41.35

0.6 (1.47%)

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Conference/Events
American Gas Association to hold a forum »

2017 Mini-Forum for the…

SR

Spire

$75.35

-0.05 (-0.07%)

MC

Moelis

$41.35

0.6 (1.47%)

ATO

Atmos Energy

$85.93

-0.57 (-0.66%)

CPK

Chesapeake Utilities

$77.40

-1.65 (-2.09%)

ED

Consolidated Edison

$83.41

-0.16 (-0.19%)

ES

Eversource

$61.77

0.08 (0.13%)

NI

NiSource

$26.40

-0.14 (-0.53%)

NWN

Northwest Natural Gas

$65.85

-0.3 (-0.45%)

OGS

ONE Gas

$74.60

-0.11 (-0.15%)

SJI

South Jersey Industries

$35.14

-0.28 (-0.79%)

UGI

UGI Corporation

$47.74

-0.17 (-0.35%)

VVC

Vectren

$66.00

-0.35 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 25

    Sep

  • 22

    Oct

  • 31

    Oct

  • 05

    Nov

SCVL

Shoe Carnival

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Upgrade
Shoe Carnival rating change  »

Shoe Carnival upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

KSS

Kohl's

$45.38

0.49 (1.09%)

, AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

08:30
09/20/17
09/20
08:30
09/20/17
08:30
Recommendations
Kohl's, Amazon.com analyst commentary  »

Citi likes Kohl's…

KSS

Kohl's

$45.38

0.49 (1.09%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 09

    Nov

MORE

Monogram Residential Trust

08:30
09/20/17
09/20
08:30
09/20/17
08:30
Options
One option delisting on September 20th »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$53.54

-4.26 (-7.37%)

08:29
09/20/17
09/20
08:29
09/20/17
08:29
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$33.99

0.28 (0.83%)

08:26
09/20/17
09/20
08:26
09/20/17
08:26
Conference/Events
Radius Health has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.